Cabaletta Bio (CABA) Other Working Capital Changes (2018 - 2025)
Cabaletta Bio (CABA) recorded quarterly Other Working Capital Changes of -$1.1 million in Q4 2025, up 74.73% quarter-over-quarter from -$4.2 million in Q3 2025, and up 58.6% on a YoY basis from -$666466.0 in Q4 2024.
Cabaletta Bio (CABA) Other Working Capital Changes (2018 - 2025) Analysis & Trends
Cabaletta Bio's Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$1.1 million for Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 58.6% year-over-year to -$1.1 million; the TTM figure through Dec 2025 stood at -$4.2 million (down 28.44% YoY), while the FY2025 annual figure was -$4.2 million, down 28.44% from the prior year.
- Other Working Capital Changes was -$1.1 million for Q4 2025 at Cabaletta Bio, up from -$4.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.7 million in Q3 2021 to a low of -$4.2 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged -$461300.0 across 5 years, with a median of -$190000.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes sank 8918.18% in 2022, then surged 394.0% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $33000.0 in 2021, then tumbled by 8918.18% to -$2.9 million in 2022, then jumped by 124.88% to $724000.0 in 2023, then plunged by 452.62% to -$2.6 million in 2024, then jumped by 58.6% to -$1.1 million in 2025.
- The last three Other Working Capital Changes figures came in at -$1.1 million (Q4 2025), -$4.2 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.06 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | -4.18 Mn |
| Sep 30, 2025 | -4.18 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | -1.06 Mn |
| Mar 31, 2025 | -1.06 Mn |
| Dec 31, 2024 | -2.55 Mn |
| Dec 31, 2024 | -2.55 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | -968,000.00 |
| Jun 30, 2024 | -968,000.00 |
| Mar 31, 2024 | -1.25 Mn |
| Mar 31, 2024 | -1.25 Mn |
| Dec 31, 2023 | 724,000.00 |
| Dec 31, 2023 | 724,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |